165 related articles for article (PubMed ID: 25858436)
1. Is riluzole a potential therapy for Rett syndrome?
Tsai SJ
Med Hypotheses; 2015 Jul; 85(1):76-8. PubMed ID: 25858436
[TBL] [Abstract][Full Text] [Related]
2. Lithium and antidepressants: potential agents for the treatment of Rett syndrome.
Tsai SJ
Med Hypotheses; 2006; 67(3):626-9. PubMed ID: 16584849
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Transcranial Focused Ultrasound for Rett Syndrome.
Tsai SJ
Med Sci Monit; 2016 Oct; 22():4026-4029. PubMed ID: 27786169
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor and Rett syndrome.
Katz DM
Handb Exp Pharmacol; 2014; 220():481-95. PubMed ID: 24668484
[TBL] [Abstract][Full Text] [Related]
5. Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.
Ben-Zeev B; Aharoni R; Nissenkorn A; Arnon R
Med Hypotheses; 2011 Feb; 76(2):190-3. PubMed ID: 20951500
[TBL] [Abstract][Full Text] [Related]
6. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.
Tsai SJ
Med Hypotheses; 2007; 68(5):1144-6. PubMed ID: 16996699
[TBL] [Abstract][Full Text] [Related]
7. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
[TBL] [Abstract][Full Text] [Related]
8. Early intervention with psychostimulants or antidepressants to increase methyl-CpG-binding protein 2 (MeCP2) expressions: a potential therapy for Rett syndrome.
Pan CH; Tsai S
Med Sci Monit; 2012 Jan; 18(1):HY1-3. PubMed ID: 22207122
[TBL] [Abstract][Full Text] [Related]
9. Peripheral administration of brain-derived neurotrophic factor to Rett syndrome animal model: a possible approach for the treatment of Rett syndrome.
Tsai SJ
Med Sci Monit; 2012 Aug; 18(8):HY33-36. PubMed ID: 22847207
[TBL] [Abstract][Full Text] [Related]
10. ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome.
Kaufmann WE; Sprouse J; Rebowe N; Hanania T; Klamer D; Missling CU
Pharmacol Biochem Behav; 2019 Dec; 187():172796. PubMed ID: 31704481
[TBL] [Abstract][Full Text] [Related]
11. Rett syndrome: of girls and mice--lessons for regression in autism.
Glaze DG
Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
[TBL] [Abstract][Full Text] [Related]
12. Social impairments in Rett syndrome: characteristics and relationship with clinical severity.
Kaufmann WE; Tierney E; Rohde CA; Suarez-Pedraza MC; Clarke MA; Salorio CF; Bibat G; Bukelis I; Naram D; Lanham DC; Naidu S
J Intellect Disabil Res; 2012 Mar; 56(3):233-47. PubMed ID: 21385260
[TBL] [Abstract][Full Text] [Related]
13. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome.
Nectoux J; Bahi-Buisson N; Guellec I; Coste J; De Roux N; Rosas H; Tardieu M; Chelly J; Bienvenu T
Neurology; 2008 May; 70(22 Pt 2):2145-51. PubMed ID: 18434641
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome.
Vigli D; Cosentino L; Raggi C; Laviola G; Woolley-Roberts M; De Filippis B
Neuropharmacology; 2018 Sep; 140():121-129. PubMed ID: 30056123
[TBL] [Abstract][Full Text] [Related]
16. The MeCP2E1/E2-BDNF-
Pejhan S; Del Bigio MR; Rastegar M
Front Cell Dev Biol; 2020; 8():763. PubMed ID: 32974336
[TBL] [Abstract][Full Text] [Related]
17. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
18. Autonomic dysfunction with mutations in the gene that encodes methyl-CpG-binding protein 2: insights into Rett syndrome.
Lioy DT; Wu WW; Bissonnette JM
Auton Neurosci; 2011 Apr; 161(1-2):55-62. PubMed ID: 21316312
[TBL] [Abstract][Full Text] [Related]
19. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
20. Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor/exploratory behaviour in a mouse model of Rett syndrome.
De Filippis B; Ricceri L; Fuso A; Laviola G
Neuropharmacology; 2013 May; 68():174-83. PubMed ID: 22709945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
